DemirkiranMSaricaYUguzSMultiple sclerosis patients with and without sexual dysfunction: Are there any differences?Mult Scler2006; 12: 209–214.
5.
ThielSLanger GouldARockhoffMInterferon-beta exposure during first trimester is safe in women with multiple sclerosis—A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry. Mult Scler2016; 22: 801–809.
6.
HerbstrittSLanger GouldARockhoffMGlatiramer acetate during early pregnancy—A prospective cohort study. Mult Scler2016; 22: 810–816.
7.
MillerAERustgiSFarrellC. Use of glatiramer acetate during pregnancy: Offering women a choice. Mult Scler2012; 18(S4): 336.
ComiGFilippiMWolinskyJS. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging—Measured disease activity and burden in patients with relapsing multiple sclerosis. Ann Neurol2001; 49: 290–297.
12.
MikolDDBarkhofFChangPComparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): A multicenter, randomized, parallel, open-label trial. Lancet Neurol2008; 7: 903–914.
13.
BoveRAlwanSFriedmanJMManagement of multiple sclerosis during pregnancy and the reproductive years: A systematic review. Obstet Gynecol2014; 124: 1157–1168.